Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Oxalyl chloride → 4-[5-(2,2'-Dimethylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Oxalyl chloride | HCID 65578 | — |
| 반응물 | p-Cyanobenzenesulphonamide | HCID 76566 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | N-hydroxy-4-sulfamoylbenzene-1-carboximidamide | HCID 612025 | — |
| 반응물 | 2,2'-Dimethyl-[1,1'-biphenyl]-4-carboxylic acid | HCID 21937303 | — |
| 생성물 | 4-[5-(2,2'-Dimethylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide | HCID 25256471 | — |
반응 단계
Oxalyl chloride (134 mL; 1.59 mmol), Intermediate 3 (120 mg; 0.53 mmol), 4-(aminosulfonyl)-N′-hydroxybenzenecarboximidamide, prepared as described in WO 2006/013104 A1 from 4-cyanobenzene-1-sulfonamide (ABCR; CD10716), (114 mg; 0.53 mmol, 1 eq.) and DIEA (274 mL; 1.59 mmol) were reacted according to the procedure described for Example 38. Purification by recrystallisation from DCM/n-pentane afforded the title compound as a white solid. LC/MS (Method A): 404.3 (M−H)−. HPLC (Method A) Rt 5.17 min (purity 95.4%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08202865B2 |
| 출처 데이터셋 | uspto-grants-2012_06 |
| ORD ID | ord-99b2fbd7fbad4bb0ad85c2da91683ad7 |
| 출처 메모 | uspto-grants-2012_06 |